Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 807Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9GlaxoSmithKline Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Rosiglitazone, Glimepiride

Brand Name : AVANDARYL

Patent Number : 1328452

Filing Date : 1988-09-02

Strength per Unit : 4 mg rosiglitazone / 1 mg glimepiride

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-04-12

Date Granted : 1994-04-12

blank

02

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Rosiglitazone, Glimepiride

Brand Name : AVANDARYL

Patent Number : 2143849

Filing Date : 1993-09-01

Strength per Unit : 4 mg rosiglitazone / 1 mg glimepiride

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-09-01

Date Granted : 2000-04-25

blank

03

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Rosiglitazone, Glimepiride

Brand Name : AVANDARYL

Patent Number : 2297115

Filing Date : 1998-07-16

Strength per Unit : 4 mg rosiglitazone / 1 mg glimepiride

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-07-16

Date Granted : 2010-02-23

blank

04

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Rosiglitazone, Glimepiride

Brand Name : AVANDARYL

Patent Number : 2297115

Filing Date : 1998-07-16

Strength per Unit : 4 mg rosiglitazone / 2 mg glimepiride

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-07-16

Date Granted : 2010-02-23

blank

05

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Rosiglitazone, Glimepiride

Brand Name : AVANDARYL

Patent Number : 1328452

Filing Date : 1988-09-02

Strength per Unit : 4 mg rosiglitazone / 2 mg glimepiride

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-04-12

Date Granted : 1994-04-12

blank

06

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Rosiglitazone, Glimepiride

Brand Name : AVANDARYL

Patent Number : 2143849

Filing Date : 1993-09-01

Strength per Unit : 4 mg rosiglitazone / 2 mg glimepiride

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-09-01

Date Granted : 2000-04-25

blank

07

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Rosiglitazone, Glimepiride

Brand Name : AVANDARYL

Patent Number : 2297115

Filing Date : 1998-07-16

Strength per Unit : 4 mg rosiglitazone / 4 mg glimepiride

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-07-16

Date Granted : 2010-02-23

blank

08

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Rosiglitazone, Glimepiride

Brand Name : AVANDARYL

Patent Number : 1328452

Filing Date : 1988-09-02

Strength per Unit : 4 mg rosiglitazone / 4 mg glimepiride

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-04-12

Date Granted : 1994-04-12

blank

09

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Rosiglitazone, Glimepiride

Brand Name : AVANDARYL

Patent Number : 2143849

Filing Date : 1993-09-01

Strength per Unit : 4 mg rosiglitazone / 4 mg glimepiride

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-09-01

Date Granted : 2000-04-25

blank